Filing Flows › LifeStance Health Group (LFST) › Q2 2025
LifeStance Health Group (LFST) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
LifeStance Health Group (LFST) reported revenue of $345M for the second quarter 2025 (Q2 2025), +11% from a year earlier and +4% from the quarter before. Operating margin was -0.9%, net loss $3.8M (1.1% of revenue).
LifeStance Health Group, Q2 2025: revenue $345M (+11% year over year), operating margin -0.9%, net loss $3.8M, operating cash flow $64.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $345M | +4% | +11% |
| Operating profit | −$3.0M | -284% | — |
| Net earnings | −$3.8M | -635% | — |
| Operating cash flow | $64.4M | — | +46% |
| Free cash flow | $56.6M | — | +45% |
What changed
Revenue was $345.3M in Q2 2025, up 11% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $3.0M, an operating margin of -0.9%. Total costs grew 6% against revenue growth of 11%. The quarter ended with a net loss of $3.8M, after a profit of $709K the previous quarter. Net interest and other expense of $3.0M was the main reason.
Operating cash flow was $64.4M (up 46% year over year). Non-cash charges added back $10.6M of depreciation and amortization and $21.1M of share-based compensation. Working capital and other items added $36.4M. Capital expenditures of $7.8M left free cash flow of $56.6M.
Questions
What was LifeStance Health Group's revenue in the second quarter 2025?
LifeStance Health Group (LFST) reported revenue of $345M for the second quarter 2025 (Q2 2025), +11% from a year earlier and +4% from the quarter before.
Was LifeStance Health Group profitable in the second quarter 2025?
Operating loss was $3.0M (-0.9% of revenue) and net loss $3.8M.